NAG Detection Kit
Tech ID
P14-1352
Patent Status
Published in India
Design Status
--
Technical Description
The present invention relates to a non-invasive method for monitoring early renal damage by detecting N-acetyl β-D-glucosaminidase (NAG) in urine samples based on fluorescence assay.
Problems Addressed
- Renal Damage
- Elevated NAG Levels
- Non-Selective Method
- Non-Sensitivity
- Expensive
- Delayed Detection
TARGET AUDIENCE
- Healthcare and Diagnostics Sector
- Pharmaceutical Industry
- Medical Device Manufacturing Sector
- Research & Development
TECH FEATURES
- NAG Detection
- Non-Invasive Method
- Early Renal Damage Detection
- Rapid Detection
- High Specificity
- Improved Stability
- Detection at Low Concentration
- Cost-Effective
- Reliable Method
P14-1352
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com